Cite
HARVARD Citation
Ndjeka, N. et al. (2022). Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study. Lancet infectious diseases. 22 (7), pp. 1042-1051. [Online].